HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,225 | -7.9% | 51,675 | +3.7% | 0.00% | – |
| Q2 2023 | $57,812 | -22.9% | 49,838 | +0.3% | 0.00% | – |
| Q1 2023 | $75,002 | -38.4% | 49,670 | +2.0% | 0.00% | -100.0% |
| Q4 2022 | $121,703 | -40.9% | 48,681 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $206,000 | +53.7% | 48,858 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $134,000 | -48.9% | 48,168 | +5.0% | 0.00% | 0.0% |
| Q1 2022 | $262,000 | -41.5% | 45,869 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $448,000 | -17.2% | 49,097 | -2.9% | 0.00% | -33.3% |
| Q3 2021 | $541,000 | -32.6% | 50,567 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $803,000 | -3.0% | 51,768 | +1.4% | 0.00% | 0.0% |
| Q1 2021 | $828,000 | -23.2% | 51,074 | +0.3% | 0.00% | -25.0% |
| Q4 2020 | $1,078,000 | +38.7% | 50,938 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $777,000 | -1.4% | 52,400 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $788,000 | +34.9% | 53,592 | +7.7% | 0.00% | +33.3% |
| Q1 2020 | $584,000 | -52.8% | 49,759 | -5.5% | 0.00% | -40.0% |
| Q4 2019 | $1,237,000 | +43.5% | 52,634 | +12.9% | 0.01% | +66.7% |
| Q3 2019 | $862,000 | -1.1% | 46,604 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $872,000 | -18.8% | 46,929 | +6.8% | 0.00% | -25.0% |
| Q1 2019 | $1,074,000 | -8.8% | 43,956 | -3.1% | 0.00% | -20.0% |
| Q4 2018 | $1,177,000 | -18.7% | 45,381 | -0.8% | 0.01% | 0.0% |
| Q3 2018 | $1,447,000 | -10.4% | 45,731 | +10.0% | 0.01% | -16.7% |
| Q2 2018 | $1,615,000 | +68.6% | 41,565 | +19.8% | 0.01% | +100.0% |
| Q1 2018 | $958,000 | +72.9% | 34,709 | +13.4% | 0.00% | +50.0% |
| Q4 2017 | $554,000 | +12.6% | 30,602 | +0.5% | 0.00% | 0.0% |
| Q3 2017 | $492,000 | +26.2% | 30,457 | +8.1% | 0.00% | +100.0% |
| Q2 2017 | $390,000 | +2.6% | 28,180 | +11.2% | 0.00% | 0.0% |
| Q1 2017 | $380,000 | +59.0% | 25,332 | +38.6% | 0.00% | 0.0% |
| Q4 2016 | $239,000 | -99.9% | 18,273 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $315,671,000 | -4.4% | 18,321 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $330,189,000 | +2.9% | 18,293 | +8.1% | 0.00% | 0.0% |
| Q1 2016 | $321,000,000 | -16.6% | 16,924 | +17.2% | 0.00% | -50.0% |
| Q4 2015 | $385,000,000 | +108965.2% | 14,435 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $353,000 | -99.9% | 14,460 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $450,044,000 | +111.2% | 14,443 | -1.4% | 0.00% | +100.0% |
| Q1 2015 | $213,099,000 | +44.6% | 14,646 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $147,339,000 | +38.6% | 14,646 | +14.8% | 0.00% | – |
| Q3 2014 | $106,291,000 | -34.8% | 12,760 | -3.6% | 0.00% | -100.0% |
| Q2 2014 | $163,018,000 | +9667.4% | 13,232 | +10926.7% | 0.00% | – |
| Q1 2014 | $1,669,000 | – | 120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |